Videos

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, discusses how the tariffs impact the reshoring of manufacturing services, alongside the strategies that pharma leaders can use in order to start shoring up their supply chains.

The Case for Reshoring Manufacturing to the United States

Articles

The latest news for pharma industry insiders.

Pharma Pulse 3/10/25: NIH’s Role in New Drug Development, Future Directions in Biosimilar Health Care Delivery & more

The US president delays tariffs that comply with the 2020 USMCA for one month, with reciprocal tariffs still expected to go into effect by April 2. 

Trump Delays Certain Tariffs on Canada and Mexico

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Tom Dorsett, CEO, RazorMetrics, describes how the software company’s solution can help deliver better patient outcomes and substantial savings for healthcare plans, employers, and members alike.

Streamlining Prescription Processes

Pharma Pulse 3/7/25: Shaping Trust Through Design, New Interest in Direct Contracting & more

The agreement—powered by YASKAWA's Maholo robot—aims to address challenges in production and commercialization while offering access to academic and startup communities.

Astellas, YASKAWA Partner to Form New Cell Therapy Manufacturing Joint Venture

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Tom Dorsett, CEO, RazorMetrics, shares the strategies that should be taken to overcome health information exchange blockages.

Overcoming Health Data Blockages in Polypharmacy

Pharma Pulse 3/6/25: Regulatory Agencies Role in Battle Against Misinformation, Developing Winning Supplemental Benefits Packages & more

NovoCare will offer the GLP-1 injection to cash-paying patients for a discounted $499 per month. 

Novo Nordisk Launches DTP Delivery Service for Wegovy

Ron Lanton, Partner, Lanton Law, examines the legal and economic impacts of reciprocal tariffs on the pharma supply chain, including potential disruptions and increased drug costs. 

News